HomeRPID • NASDAQ
Rapid Micro Biosystems Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 7.21M | 28.41% |
Operating expense | 12.07M | -5.37% |
Net income | -11.26M | 15.46% |
Net profit margin | -156.32 | 34.16% |
Earnings per share | -0.26 | 16.13% |
EBITDA | -10.92M | 19.51% |
Effective tax rate | -0.06% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 41.67M | -48.09% |
Total assets | 85.43M | -33.11% |
Total liabilities | 19.94M | -8.47% |
Total equity | 65.49M | — |
Shares outstanding | 43.99M | — |
Price to book | 2.01 | — |
Return on assets | -31.76% | — |
Return on capital | -38.14% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -11.26M | 15.46% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
$3.00
Day range
$2.90 - $3.15
Year range
$0.58 - $4.04
Market cap
134.12M USD
Avg Volume
165.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2006
Headquarters
Website
Employees
163